Literature DB >> 11714731

Autoantibodies as predictors of disease.

D Leslie1, P Lipsky, A L Notkins.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11714731      PMCID： PMC209428          DOI： 10.1172/JCI14452

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  46 in total

1.  Autoimmune type 1 diabetes: resolved and unresolved issues.

Authors:  A L Notkins; A Lernmark
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

2.  Thyroid autoimmunity.

Authors:  B Rapoport; S M McLachlan
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

3.  Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.

Authors:  J Seissler; N G Morgenthaler; P Achenbach; E F Lampeter; D Glawe; M Payton; M Christie; W A Scherbaum
Journal:  Diabetologia       Date:  1996-11       Impact factor: 10.122

4.  Natural history of early primary biliary cirrhosis.

Authors:  J V Metcalf; H C Mitchison; J M Palmer; D E Jones; M F Bassendine; O F James
Journal:  Lancet       Date:  1996-11-23       Impact factor: 79.321

Review 5.  Chronic autoimmune thyroiditis.

Authors:  C M Dayan; G H Daniels
Journal:  N Engl J Med       Date:  1996-07-11       Impact factor: 91.245

6.  II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease.

Authors:  C Betterle; M Volpato; B Rees Smith; J Furmaniak; S Chen; R Zanchetta; N A Greggio; B Pedini; M Boscaro; F Presotto
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

7.  I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease.

Authors:  C Betterle; M Volpato; B Rees Smith; J Furmaniak; S Chen; N A Greggio; M Sanzari; F Tedesco; B Pedini; M Boscaro; F Presotto
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

8.  IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.

Authors:  F K Gorus; P Goubert; C Semakula; C L Vandewalle; J De Schepper; A Scheen; M R Christie; D G Pipeleers
Journal:  Diabetologia       Date:  1997-01       Impact factor: 10.122

9.  Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies.

Authors:  C F Verge; R Gianani; E Kawasaki; L Yu; M Pietropaolo; R A Jackson; H P Chase; G S Eisenbarth
Journal:  Diabetes       Date:  1996-07       Impact factor: 9.461

10.  Changing autoantibody profiles with variable clinical manifestations in a patient with relapsing systemic lupus erythematosus and polymyositis.

Authors:  M Satoh; K Miyazaki; T Mimori; M Akizuki; Y Ichikawa; M Homma; A K Ajmani; W H Reeves
Journal:  Br J Rheumatol       Date:  1995-10
View more
  44 in total

1.  Autoimmune type 1 diabetes: resolved and unresolved issues.

Authors:  A L Notkins; A Lernmark
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 2.  Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.

Authors:  E M Tan; F-D Shi
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

Review 3.  Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases.

Authors:  C Hu; F S Wong; L Wen
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

4.  Circulating 25-hydroxyvitamin D level and risk of developing rheumatoid arthritis.

Authors:  Linda T Hiraki; Elizabeth V Arkema; Jing Cui; Susan Malspeis; Karen H Costenbader; Elizabeth W Karlson
Journal:  Rheumatology (Oxford)       Date:  2014-07-26       Impact factor: 7.580

Review 5.  Checkpoints that control B cell development.

Authors:  Fritz Melchers
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

Review 6.  Environmental and gene-environment interactions and risk of rheumatoid arthritis.

Authors:  Elizabeth W Karlson; Kevin Deane
Journal:  Rheum Dis Clin North Am       Date:  2012-05-30       Impact factor: 2.670

7.  Light chain inclusion permits terminal B cell differentiation and does not necessarily result in autoreactivity.

Authors:  C Sirac; C Carrion; S Duchez; I Comte; M Cogné
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

8.  Innate stimulation of B1a cells enhances the autoreactive IgM repertoire in the NOD mouse: implications for type 1 diabetes.

Authors:  J Côrte-Real; N Duarte; L Tavares; C Penha-Gonçalves
Journal:  Diabetologia       Date:  2012-03-01       Impact factor: 10.122

9.  Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus.

Authors:  Giovane R Sousa; David Pober; Alfonso Galderisi; HuiJuan Lv; Liping Yu; Alexandre C Pereira; Alessandro Doria; Mikhail Kosiborod; Myra A Lipes
Journal:  Circulation       Date:  2019-02-05       Impact factor: 29.690

Review 10.  Antibodies specific for disease-associated antigens (DAA) expressed in non-malignant diseases reveal potential new tumor-associated antigens (TAA) for immunotherapy or immunoprevention.

Authors:  Camille Jacqueline; Olivera J Finn
Journal:  Semin Immunol       Date:  2020-04-06       Impact factor: 11.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.